A common uptake system for serotonin and dopamine in human platelets
- PMID: 670392
- PMCID: PMC371758
- DOI: 10.1172/JCI109121
A common uptake system for serotonin and dopamine in human platelets
Abstract
Kinetic and pharmacologic properties of uptake of serotonin and dopamine by normal human platelets have been investigated to test whether platelets can be employed as a model system for the reuptake of serotonin and dopamine in brain. Uptake of serotonin into platelets closely resembles reuptake of serotonin into serotonergic neurons. In contrast, uptake of dopamine into platelets appears to be mediated inefficiently via the specific serotonin uptake mechanism, based upon several lines of evidence. Serotonin and dopamine compete with each other, Antidepressant drugs, which are competitive inhibitors of uptake of both of these neurotransmitters, act at the same concentration of drug despite large differences in the Km values. Serotonin antagonists inhibit both serotonin and dopamine uptake. Finally, a serotonin-specific uptake inhibitor (fluoxetine) blocks dopamine, as well as serotonin, uptake.
Similar articles
-
Uptake of 5-hydroxytryptamine and dopamine into platelets from depressed patients and normal subjects--influence of clomipramine, desmethylclomipramine and maprotiline.Postgrad Med J. 1980;56 Suppl 1:31-5. Postgrad Med J. 1980. PMID: 7393826
-
A kinetic and pharmacologic analysis of 5-hydroxytryptamine transport by human platelets and platelet storage granules: comparison with central serotonergic neurons.J Pharmacol Exp Ther. 1978 Apr;205(1):118-32. J Pharmacol Exp Ther. 1978. PMID: 633077
-
The effects of prodipine and budipine on 14C-5-hydroxytryptamine uptake and release by human blood platelets.Arzneimittelforschung. 1980;30(7):1129-34. Arzneimittelforschung. 1980. PMID: 7191294
-
Antidepressants and the serotonin uptake in platelets.Acta Psychiatr Scand Suppl. 1980;280:111-9. Acta Psychiatr Scand Suppl. 1980. PMID: 6996427 Review. No abstract available.
-
Pharmacological effects of serotonin reuptake inhibitors.J Clin Psychiatry. 1988 Aug;49 Suppl:12-7. J Clin Psychiatry. 1988. PMID: 3045106 Review.
Cited by
-
Biochemical assessment of antidepressive drugs.Br J Clin Pharmacol. 1980 Dec;10(6):539-50. doi: 10.1111/j.1365-2125.1980.tb00508.x. Br J Clin Pharmacol. 1980. PMID: 6110435 Free PMC article. Review. No abstract available.
-
A study of gamma-aminobutyric acid uptake in normal and Down's syndrome platelets.Br J Pharmacol. 1980;71(2):553-6. doi: 10.1111/j.1476-5381.1980.tb10972.x. Br J Pharmacol. 1980. PMID: 6451255 Free PMC article.
-
Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.J Neural Transm Gen Sect. 1994;96(3):165-77. doi: 10.1007/BF01294784. J Neural Transm Gen Sect. 1994. PMID: 7826568
-
Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter.Naunyn Schmiedebergs Arch Pharmacol. 1992 Feb;345(2):129-36. doi: 10.1007/BF00165727. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1570019
-
Platelets and biogenic amines. 1. Platelets are poor investigative models for dopamine re-uptake.Psychopharmacology (Berl). 1984;84(4):480-5. doi: 10.1007/BF00431453. Psychopharmacology (Berl). 1984. PMID: 6441948
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources